2021
DOI: 10.1159/000512826
|View full text |Cite
|
Sign up to set email alerts
|

A Complicated Case of Diffuse Large B-Cell Lymphoma in an Elderly Presenting with Massive Gastrointestinal Bleeding Successfully Treated with R-mini CHOP

Abstract: Gastrointestinal lymphoma accounts for up to 20% of all extranodal lymphoma cases. Among them, the ileum is the second most commonly affected site after the stomach. The majority of gastrointestinal lymphoma originates from the B cell lineage. We report the case of 60-year-old male with persistent anemia, hematochezia, and poor performance status (PS). After thorough workup, imaging, and pathological study, the patient was diagnosed with diffuse large B-cell lymphoma of the terminal ileum. He was treated with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 13 publications
0
2
0
1
Order By: Relevance
“…The addition of rituximab has resulted in a reduced need for surgical intervention. In cases of localized disease in the small intestine, there may still be a surgical role in combination with R-CHOP [12]. Most surgeries performed in cases of intestinal NHL are emergency laparotomies [13], similarly to the above case.…”
Section: Discussionmentioning
confidence: 96%
“…The addition of rituximab has resulted in a reduced need for surgical intervention. In cases of localized disease in the small intestine, there may still be a surgical role in combination with R-CHOP [12]. Most surgeries performed in cases of intestinal NHL are emergency laparotomies [13], similarly to the above case.…”
Section: Discussionmentioning
confidence: 96%
“…The proposed first-line regimen for extranodal gastrointestinal DLBCL is the use of CHOP or R-CHOP chemotherapy protocols. Most of the reports give a significant advantage of the rituximab addition to the CHOP protocol in terms of significantly greater overall survival and progression-free survival [13,14].…”
Section: Discussionmentioning
confidence: 99%
“…Tất cả các trường hợp u lympho tế bào B lớn lan tỏa ở nghiên cứu này đều có hình thái lan tỏa (100%), hầu hết các trường hợp tế bào u có kích thước lớn (79,3%). Theo y văn cũng như các nghiên cứu trước đây, u lympho tế bào B lớn lan tỏa ở dạ dày -ruột có đặc điểm mô bệnh học giống như u lympho tại hạch với các tế bào u có kích thước lớn, hình thái xâm nhập lan tỏa [13], [14].…”
Section: đặC đIểm Mô Học Và Tế Bào Các U Lympho Dạ Dày -Ruột Thường Gặpunclassified